148 related articles for article (PubMed ID: 34223985)
1. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
Kawamura H; Ogawa Y; Yamazaki H; Honda M; Kono K; Konno S; Fukuhara S; Yamamoto Y
World J Surg; 2021 Oct; 45(10):3230-3239. PubMed ID: 34223985
[TBL] [Abstract][Full Text] [Related]
2. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
[TBL] [Abstract][Full Text] [Related]
3. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
[TBL] [Abstract][Full Text] [Related]
4. Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer.
Inci K; Nilsson B; Lindskog S; Giglio D
ANZ J Surg; 2023 Nov; 93(11):2680-2685. PubMed ID: 37489624
[TBL] [Abstract][Full Text] [Related]
5. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.
Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y
Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147
[TBL] [Abstract][Full Text] [Related]
8. Influence of primary tumor location and resection on survival in metastatic colorectal cancer.
Tharin Z; Blanc J; Alaoui IC; Bertaut A; Ghiringhelli F
World J Gastrointest Oncol; 2020 Nov; 12(11):1296-1310. PubMed ID: 33250962
[TBL] [Abstract][Full Text] [Related]
9. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
Ergun Y; Bal O; Dogan M; Ucar G; Dirikoc M; Acikgoz Y; Bacaksiz F; Uncu D
J Res Med Sci; 2020; 25():14. PubMed ID: 32174986
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of primary tumor resection versus chemotherapy in patients with asymptomatic unresectable metastatic colorectal cancer: a retrospective cohort study using the target trial emulation framework.
Wu CC; Su CC; Lee PT; Chen YH; Hsu CW; Su YC
Am J Cancer Res; 2024; 14(5):2172-2186. PubMed ID: 38859829
[TBL] [Abstract][Full Text] [Related]
11. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; Van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Hadj JO; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M;
Ann Oncol; 2024 Jun; ():. PubMed ID: 38852675
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.
Alawadi Z; Phatak UR; Hu CY; Bailey CE; You YN; Kao LS; Massarweh NN; Feig BW; Rodriguez-Bigas MA; Skibber JM; Chang GJ
Cancer; 2017 Apr; 123(7):1124-1133. PubMed ID: 27479827
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases.
Chen Q; Li K; Rhodin KE; Masoud SJ; Lidsky ME; Cai J; Wei Q; Luo S; Zhao H
J Surg Oncol; 2023 May; 127(6):945-955. PubMed ID: 36807890
[TBL] [Abstract][Full Text] [Related]
14. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
van der Kruijssen DEW; Elias SG; Vink GR; van Rooijen KL; 't Lam-Boer J; Mol L; Punt CJA; de Wilt JHW; Koopman M;
JAMA Surg; 2021 Dec; 156(12):1093-1101. PubMed ID: 34613339
[TBL] [Abstract][Full Text] [Related]
15. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
[TBL] [Abstract][Full Text] [Related]
16. Primary Tumor Resection Is Associated with Improved Survival in Stage IV Colorectal Cancer: An Instrumental Variable Analysis.
Xu H; Xia Z; Jia X; Chen K; Li D; Dai Y; Tao M; Mao Y
Sci Rep; 2015 Nov; 5():16516. PubMed ID: 26563729
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
18. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
[TBL] [Abstract][Full Text] [Related]
19. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
Front Oncol; 2022; 12():930491. PubMed ID: 35912176
[TBL] [Abstract][Full Text] [Related]
20. Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.
Polcz M; Schlegel C; Edwards GC; Wang F; Tan M; Kiernan C; Solórzano CC; Idrees K; Parikh A; Bailey CE
Ann Surg Oncol; 2020 Aug; 27(8):2795-2803. PubMed ID: 32430752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
